Two Sigma Advisers’s Marinus Pharmaceuticals, Inc MRNS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-19,725
| Closed | -$34.7K | – | 2595 |
|
|
2024
Q3 | $34.7K | Sell |
19,725
-22,900
| -54% | -$40.3K | ﹤0.01% | 2233 |
|
|
2024
Q2 | $49.9K | Sell |
42,625
-100
| -0.2% | -$117 | ﹤0.01% | 2366 |
|
|
2024
Q1 | $386K | Buy |
+42,725
| New | +$386K | ﹤0.01% | 1973 |
|
|
2023
Q4 | – | Sell |
-19,725
| Closed | -$159K | – | 2679 |
|
|
2023
Q3 | $159K | Sell |
19,725
-54,300
| -73% | -$437K | ﹤0.01% | 2139 |
|
|
2023
Q2 | $804K | Buy |
+74,025
| New | +$804K | ﹤0.01% | 1617 |
|
|
2021
Q4 | – | Sell |
-18,175
| Closed | -$207K | – | 2846 |
|
|
2021
Q3 | $207K | Sell |
18,175
-64,850
| -78% | -$739K | ﹤0.01% | 2239 |
|
|
2021
Q2 | $1.49M | Sell |
83,025
-31,625
| -28% | -$567K | ﹤0.01% | 1445 |
|
|
2021
Q1 | $1.78M | Buy |
114,650
+18,202
| +19% | +$282K | ﹤0.01% | 1324 |
|
|
2020
Q4 | $1.18M | Sell |
96,448
-9,800
| -9% | -$120K | ﹤0.01% | 1487 |
|
|
2020
Q3 | $1.37M | Buy |
106,248
+74,323
| +233% | +$955K | ﹤0.01% | 1359 |
|
|
2020
Q2 | $324K | Buy |
31,925
+28,875
| +947% | +$293K | ﹤0.01% | 2093 |
|
|
2020
Q1 | $25K | Buy |
3,050
+250
| +9% | +$2.05K | ﹤0.01% | 2407 |
|
|
2019
Q4 | $24K | Sell |
2,800
-575
| -17% | -$4.93K | ﹤0.01% | 2320 |
|
|
2019
Q3 | $21K | Sell |
3,375
-8,600
| -72% | -$53.5K | ﹤0.01% | 2184 |
|
|
2019
Q2 | $199K | Sell |
11,975
-1,400
| -10% | -$23.3K | ﹤0.01% | 2133 |
|
|
2019
Q1 | $224K | Buy |
13,375
+700
| +6% | +$11.7K | ﹤0.01% | 2087 |
|
|
2018
Q4 | $146K | Buy |
+12,675
| New | +$146K | ﹤0.01% | 2183 |
|